IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est

[Latest] Global eClinical Solutions Market Size/Share Worth USD 42.55 Billion by 2035 at a 13.98% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global eClinical Solutions market is projected to grow from USD 11.50 billion in 2025 to USD 42.55 billion by 2035, at a CAGR of 13.98%. Growth is driven by increased demand for efficient clinical trials, rising chronic disease prevalence, adoption of AI and cloud computing technologies, and decentralized trial models. Key players include Oracle, Veeva Systems, IQVIA, Medidata Solutions, and IBM Watson Health.

IQVIA And Medera Announce Strategic Collaboration To Accelerate Cardiac Gene Therapy Development And Human-Based Drug Discovery Platforms

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA CEO Ari Bousbib sold approximately 106,000 shares worth $26.1 million through an exercise-and-sell of expiring stock appreciation rights. The sale follows a strong Q2 earnings report with record clinical bookings of $3.15 billion and 8.7% revenue growth. Bousbib maintains a substantial 1.4 million share position, indicating the sale was routine calendar management rather than a bearish signal.

JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285